Pharma & Biotech

Pharmaceutical giant Pfizer has framed 2026 as a definitive transitional period. The company's latest financial projections for revenue and earnings...

As Anixa Biosciences approaches its next earnings release, the company's stock is trading under significant technical pressure. Market participants are...

Eli Lilly and Company is entering 2026 with significant strategic and financial momentum, its shares trading at record highs on...

Healwell AI Inc. has entered 2026 navigating a complex landscape shaped by regulatory pressure and a fundamental strategic shift. The...

A notable upgrade from analysis platform Wall Street Zen has introduced a contrasting perspective on Organon & Co., setting it...

Shares of Capricor Therapeutics are undergoing a reassessment by market experts, reflecting a shift in sentiment. The biotech firm's stock,...

The investment thesis for pharmaceutical giant Novo Nordisk is undergoing a significant reassessment. While the company celebrates a key regulatory...

Entering the new year, BioNxt Solutions (BNXT) carries significant momentum, with investor focus shifting from near-term volatility to a clearly...

The new trading year has begun on a positive note for CureVac, with its shares posting significant gains. This upward...

Johnson & Johnson shares are trading near record highs, yet major institutional investors are sending mixed signals through their recent...